Your browser doesn't support javascript.
loading
MRI T2 mapping assessment of T2 relaxation time in desmoid tumors as a quantitative imaging biomarker of tumor response: preliminary results.
Souza, Felipe F; D'Amato, Gina; Jonczak, Emily Elizabeth; Costa, Philippos; Trent, Jonathan C; Rosenberg, Andrew E; Yechieli, Raphael; Temple, H Thomas; Pattany, Pradip; Subhawong, Ty K.
Afiliação
  • Souza FF; Department of Radiology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.
  • D'Amato G; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United States.
  • Jonczak EE; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United States.
  • Costa P; Department of Internal Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.
  • Trent JC; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United States.
  • Rosenberg AE; Department of Internal Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.
  • Yechieli R; Department of Internal Medicine, Yale Medicine, New Haven, CT, United States.
  • Temple HT; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United States.
  • Pattany P; Department of Internal Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.
  • Subhawong TK; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United States.
Front Oncol ; 13: 1286807, 2023.
Article em En | MEDLINE | ID: mdl-38188297
ABSTRACT

Objectives:

Because size-based imaging criteria poorly capture biologic response in desmoid-type fibromatosis (DF), changes in MRI T2 signal intensity are frequently used as a response surrogate, but remain qualitative. We hypothesized that absolute quantification of DF T2 relaxation time derived from parametric T2 maps would be a feasible and effective imaging biomarker of disease activity.

Methods:

This IRB-approved retrospective study included 11 patients with DF, managed by observation or systemic therapy, assessed by 3T MRI. Tumor maximum diameter, volume, and T2-weighted signal intensity were derived from manual tumor segmentations. Tumormuscle T2 signal ratios were recorded. Two readers measured tumor T2 relaxation times using a commercial T2 scanning sequence, manual ROI delineation and commercial calculation software enabling estimation of reader reliability. Objective response rates based on RECIST1.1 and best responses were compared between size-based and signal-based parameters.

Results:

Median patient age was 52.6 years; 8 subjects were female (73%). Nine patients with longitudinal assessments were followed for an average of 314 days. Median baseline tumor diameter was 7.2 cm (range 4.4 - 18.2 cm). Median baseline T2 was 65.1 ms (range 40.4 - 94.8 ms, n=11); median at last follow-up was 44.3 ms (-32% from baseline; range 29.3 - 94.7 ms, n=9). T2 relaxation times correlated with tumormuscle T2 signal ratios, Spearman p=0.78 (p<0.001). T2 mapping showed high inter-reader reliability, ICC=0.84. The best response as a percentage change in T2 values was statistically significant (mean -17.9%, p=0.05, paired t-test) while change in diameter was not (mean -8.9%, p=0.12).

Conclusions:

Analysis of T2 relaxation time maps of DF may offer a feasible quantitative biomarker for assessing the extent of response to treatment. This approach may have high inter-reader reliability.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Qualitative_research Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Qualitative_research Idioma: En Ano de publicação: 2023 Tipo de documento: Article